SE8405632L - Oxazolidiner - Google Patents

Oxazolidiner

Info

Publication number
SE8405632L
SE8405632L SE8405632A SE8405632A SE8405632L SE 8405632 L SE8405632 L SE 8405632L SE 8405632 A SE8405632 A SE 8405632A SE 8405632 A SE8405632 A SE 8405632A SE 8405632 L SE8405632 L SE 8405632L
Authority
SE
Sweden
Prior art keywords
signifies
treatment
mono
phenyl
oxazolidines
Prior art date
Application number
SE8405632A
Other languages
English (en)
Other versions
SE8405632D0 (sv
SE463099B (sv
Inventor
L Alig
M Muller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8405632D0 publication Critical patent/SE8405632D0/sv
Publication of SE8405632L publication Critical patent/SE8405632L/sv
Publication of SE463099B publication Critical patent/SE463099B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8405632A 1983-11-10 1984-11-09 2-laegre-karbalkoxi-n-aralkyl-5-(fenoximetyl-eller fenyl) oxazolidin SE463099B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20

Publications (3)

Publication Number Publication Date
SE8405632D0 SE8405632D0 (sv) 1984-11-09
SE8405632L true SE8405632L (sv) 1985-05-11
SE463099B SE463099B (sv) 1990-10-08

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405632A SE463099B (sv) 1983-11-10 1984-11-09 2-laegre-karbalkoxi-n-aralkyl-5-(fenoximetyl-eller fenyl) oxazolidin

Country Status (22)

Country Link
US (2) US4743604A (sv)
AT (1) AT387771B (sv)
AU (1) AU576531B2 (sv)
BE (1) BE900983A (sv)
CA (1) CA1249992A (sv)
DE (1) DE3438411A1 (sv)
DK (1) DK520584A (sv)
ES (1) ES8606863A1 (sv)
FI (1) FI844152L (sv)
FR (1) FR2554814B1 (sv)
GB (1) GB2149405B (sv)
HU (1) HU193465B (sv)
IL (1) IL73427A (sv)
IT (1) IT1177033B (sv)
LU (1) LU85631A1 (sv)
MC (1) MC1641A1 (sv)
NL (1) NL8403308A (sv)
NO (1) NO844501L (sv)
NZ (1) NZ210105A (sv)
PH (1) PH22462A (sv)
PT (1) PT79485B (sv)
SE (1) SE463099B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8571617B2 (en) * 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
GB2149405B (en) 1987-07-01
US4743604A (en) 1988-05-10
GB2149405A (en) 1985-06-12
US4871755A (en) 1989-10-03
HUT36103A (en) 1985-08-28
ATA355384A (de) 1988-08-15
AU3527584A (en) 1985-05-16
MC1641A1 (fr) 1986-01-09
ES8606863A1 (es) 1986-05-01
FI844152L (fi) 1985-05-11
IT1177033B (it) 1987-08-26
DE3438411A1 (de) 1985-05-30
GB8428335D0 (en) 1984-12-19
FI844152A0 (fi) 1984-10-22
IL73427A0 (en) 1985-02-28
PH22462A (en) 1988-09-12
HU193465B (en) 1987-10-28
CA1249992A (en) 1989-02-14
IT8423307A0 (it) 1984-10-25
DK520584D0 (da) 1984-11-01
AU576531B2 (en) 1988-09-01
NZ210105A (en) 1988-10-28
ES537487A0 (es) 1986-05-01
BE900983A (fr) 1985-05-06
IT8423307A1 (it) 1986-04-25
PT79485B (en) 1987-01-13
AT387771B (de) 1989-03-10
FR2554814A1 (fr) 1985-05-17
SE8405632D0 (sv) 1984-11-09
SE463099B (sv) 1990-10-08
LU85631A1 (fr) 1986-06-04
PT79485A (en) 1984-12-01
IL73427A (en) 1988-02-29
FR2554814B1 (fr) 1988-03-11
NL8403308A (nl) 1985-06-03
DK520584A (da) 1985-05-11
NO844501L (no) 1985-05-13

Similar Documents

Publication Publication Date Title
SE8405632D0 (sv) Oxazolidiner
FI872589A (fi) Pyridinetanolaminderivat och deras framstaellning.
DK217184D0 (da) Fluoralkoxyforbindelser
KR850003718A (ko) 피라졸류 제초제에 대한 개량
ES2052508T3 (es) Empleo de heteroariletilaminas para favorecer el rendimiento en animales, heteroariletilaminas y procedimiento para su obtencion.
ES8300745A1 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ATE31306T1 (de) Chinazolinon-derivate wirksam gegen coccidiosis.
ATE19509T1 (de) Substituierte benzylcycloalkenylharnstoffderivate.
ES8307205A1 (es) Un procedimiento para la preparacion de-amino acidos n-sustituidos.
IL72750A0 (en) N-substituted 5-(substituted phenyl)-1,3-oxazolidines and their use as herbicidal antidotes
ATE87610T1 (de) Propanolaminderivate.
ATE27268T1 (de) Substituierte alkanthiocarbonsaeure-derivate.
ES470195A1 (es) Procedimiento para la preparacion de anilidas de acido ci- clopropancarboxilico
GB1542749A (en) N,n-dimethyl-aminoalkyl-3',4'-dihalo-anilides methods for their preparation and compositions containing them
PT77466B (de) Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide verfahren zu ihrer herstellung ihre verwendung und diese verbindungen enthaltende arzneimittel
JPS5283850A (en) Heterocyclic compounds
KR900004343A (ko) 간질 치료용 피라졸로피리딘
ES8602732A1 (es) Procedimiento de preparacion del hidrocloruro de 1-(2-(5-dimetilaminometil-2-(furilmetiltio)-etil)-amino-1-metilamino-2-nitroetileno
ES429204A1 (es) Procedimiento para la obtencion de n-(2-(n'-ciclohexil-n' -metil - n'metilen)-4,6-dibromo-fenil)-3-etoxi-4 - valeriano-xi - benzamida, hidrocloruro.
KR900014364A (ko) 신규한 1- 디페닐메틸 피페리딘 유도체의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8405632-4

Effective date: 19930610

Format of ref document f/p: F